a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia
Industry Biotechnology
A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.
Ticker / NAME | Correlation To LRMR | 1D Price Change % | ||
---|---|---|---|---|
LRMR | 100% | -12.17% | ||
SVRA - LRMR | 41% Loosely correlated | -15.14% | ||
ROIV - LRMR | 40% Loosely correlated | +2.66% | ||
ACLX - LRMR | 38% Loosely correlated | -0.34% | ||
IDYA - LRMR | 36% Loosely correlated | -1.58% | ||
ABSI - LRMR | 36% Loosely correlated | -13.74% | ||
More |
Ticker / NAME | Correlation To LRMR | 1D Price Change % |
---|---|---|
LRMR | 100% | -12.17% |
biopharmaceutical theme (10 stocks) | 42% Loosely correlated | -2.76% |
treatment theme (56 stocks) | 35% Loosely correlated | -1.12% |
therapeutics theme (53 stocks) | 31% Poorly correlated | -2.44% |